American Journal of Hematology 2014-08-01

Females with FVIII and FIX deficiency have reduced joint range of motion.

Robert F Sidonio, Fatima D Mili, Tengguo Li, Connie H Miller, William C Hooper, Michael R DeBaun, Michael Soucie

Index: Am. J. Hematol. 89(8) , 831-6, (2014)

Full Text: HTML

Abstract

Little is known about rates of joint bleeding among females with FVIII/FIX deficiency or hemophilia carriers. In a cross-sectional study, we tested the hypothesis that females with FVIII or FIX deficiency enrolled in the Universal Data Collection (UDC) project had a reduced mean overall joint range of motion (ROM) compared with historic controls from the Normal Joint Study. Demographics, clinical characteristics, and joint ROM measurements on 303 females without a bleeding disorder and 148 females with FVIII and FIX deficiency, respectively, between the ages of 2-69 years and a body mass index (BMI) ≤ 35 were compared. Multivariate linear regression was performed with the overall joint ROM (sum of the right and left ROM measurements of five joints) as the dependent variable and FVIII or FIX activity as the independent variable adjusting for age, race, BMI, and number of joint bleeds reported over the last 6 months. As FVIII and FIX activity decreased, the mean overall joint ROM became reduced and in most cases was significantly lower than that of the controls regardless of age and clinical hemophilia severity. Further investigation of reduced joint ROM as evidence of subclinical joint bleeding in females with FVIII and FIX deficiency is warranted.© 2014 Wiley Periodicals, Inc.


Related Compounds

Related Articles:

Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS.

2014-08-01

[Biochem. J. 461(3) , 443-51, (2014)]

Regeneration of cirrhotic liver in rabbits after intrahepatic injection of cryoprecipitate.

2013-01-01

[Bull. Exp. Biol. Med. 154(3) , 396-8, (2013)]

Platelets and bleeding in the dental patient. It's not always from "blood thinners". Von Willebrand disease--clinical assessment and case report.

2013-04-01

[J. N. J. Dent. Assoc. 84(2) , 28-30, (2013)]

An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.

2014-04-01

[Ann. Hematol. 93(4) , 683-92, (2014)]

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study.

2013-03-01

[JAMA Surg. 148(3) , 218-25, (2013)]

More Articles...